Close

Keryx Biopharmaceuticals, Inc. (KERX) Misses Q3 EPS by 1c

November 7, 2012 4:43 PM EST Send to a Friend
Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) reported Q3 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login